CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss. [electronic resource]
Producer: 20160330Description: 69-79 p. digitalISSN:- 1479-6813
- Aromatase Inhibitors -- therapeutic use
- Bone Density -- drug effects
- Bone and Bones -- drug effects
- Breast Neoplasms -- drug therapy
- Cholesterol Side-Chain Cleavage Enzyme -- genetics
- Estrogens -- genetics
- Female
- Genotype
- Humans
- Middle Aged
- Osteoblasts -- drug effects
- Osteoporosis, Postmenopausal -- genetics
- Polymorphism, Single Nucleotide -- genetics
- Vitamin D -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.